Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Genome-mining tool reveals new antibiotic hidden in a silent gene cluster

15

Jul 2026

Genome-mining tool reveals new antibiotic hidden in a silent gene cluster

Researchers developed DiscERN, a genome-mining platform that combines four complementary algorithms to identify evolutionarily related biosynthetic gene clusters and prioritize candidates for experimental study. The approach revealed discomycin A, a previously unknown calcium-dependent lipopeptide antibiotic with potent activity against several Gram-positive bacteria.

Fruit fly study uncovers gene behind seasonal winter dormancy

15

Jul 2026

Fruit fly study uncovers gene behind seasonal winter dormancy

Researchers at Washington State University have discovered a molecular "winter lock" that keeps animals in a less active winter state until favorable conditions return, a discovery that could improve pest control and lead to a better understanding of seasonal health conditions in humans.

Sustainable diets may transform global food systems by 2050

15

Jul 2026

Sustainable diets may transform global food systems by 2050

There is a clear need to shift towards healthier and more sustainable food systems. According to the 2025 EAT-Lancet Commission Report, the global adoption of a flexitarian Planetary Health Diet could prevent around 15 million premature adult deaths per year.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.